Navigation Links
UT Southwestern receives continued NIH funding for Inner City Asthma Consortium
Date:11/22/2009

can make asthma worse in people who are sensitive to particular allergens.

"The goal of our mechanistic studies is to define how allergens interfere with immune responses to respiratory viruses. We will also investigate whether anti-IgE therapy improves these responses to seasonal viral infections in patients with asthma," Dr. Gill said.

The consortium is administered by the University of Wisconsin-Madison. In addition to UT Southwestern, research is being conducted at Boston University School of Medicine; Children's Memorial Hospital in Chicago; George Washington University School of Medicine and Health Sciences in Washington, D.C.; National Jewish Health in Denver; Johns Hopkins University School of Medicine; University of California, San Francisco; Columbia University College of Physicians and Surgeons in New York City; and the Henry Ford Hospital in Detroit.


'/>"/>

Contact: Erin Prather Stafford
erin.pratherstafford@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

0

GOOD

Page: 1 2

Related medicine news :

1. Director of UT Southwestern center honored with first international neurology medal
2. UT Southwestern Responds to VA Announcement
3. UT Southwestern physicians bust myths about insulin
4. UT Southwestern researchers launch study into search-and-destroy antigen for deadly skin cancer
5. Dysport proves safe, effective anti-wrinkle treatment, UT Southwestern plastic surgeons find
6. Higher drug doses needed to defeat tuberculosis, UT Southwestern researchers report
7. UT Southwestern, UT Arlington to develop magnetic surgery tools
8. UT Southwestern researcher named HHMI Early Career Physician-Scientist
9. Former Gov. Bill Clements Makes Historic Gift to UT Southwestern With $100 Million Transformative Contribution
10. UT Southwesterns Olson wins prestigious French award for heart research
11. Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT Southwestern receives continued NIH funding for Inner City Asthma Consortium
UT Southwestern receives continued NIH funding for Inner City Asthma Consortium
(Date:3/16/2010)... Noni International is Leaving the Superfruits Behind , ... ... (TNI) announced that their flagship product will no longer be ... Noni® Original Bioactive Beverage™ . Although the name is changing, Tahitian ... used by millions of people around the world for years. The ...
(Date:3/16/2010)... for local patients , ... Palo Alto, CA (PRWEB) ... Autism is a developmental disorder with impairments in social interaction and ... rare, 1 in every 150 children in the United States is ... , , ,Diagnosis of Autism typically occurs at about 3 ...
(Date:3/16/2010)... has now introduced anti aging ingredients to its already popular ... , ... (PRWEB) March 16, 2010 -- ... most complete skin brightener available. , , ,Age spots, liver ... are fading into history with the proliferation of skin lighteners. ...
(Date:3/16/2010)... Dental Systems, Inc. (EDS) announces the introduction of the ... glide path for effortless endodontic instrumentation, the SafeSiders glide ... , ... (PRWEB) ... announces the introduction of the SafeSiders Glide Path Kit. ...
(Date:3/16/2010)... residual income in the current economy, and who are looking ... GBG system offered by independent businessman Brad Aspin. Aspin is ... ... (PRWEB) March 16, 2010 -- Independent businessman Brad ... the GBG 10-in-One Liquid Multivitamin and Mineral Formula, ...
Breaking Medicine News(10 mins):Health News:Tahitian Noni Juice Is Now Tahitian Noni Original Bioactive Beverage 2Health News:Autism Research Study Announced By Children's Health Council 2Health News:Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients 2Health News:Brad Aspin and Health and Wellness Company GBG Now Looking for Leaders Nationwide 2
... not entirely prevent transmission, study finds ... hospitals and other health-care facilities with endemic methicillin-resistant ... should be combined with other measures to help ... Swiss and South African authors, who reviewed data ...
... of 100% Prefilled Syringes and Complete ACR Accreditation Demonstrate ... Company,s ... Desert Radiologists, Nevada,s,largest and most trusted medical imaging ... to administer contrast media,and the company has undergone an ...
... Online Health Insurance Marketplace, NEW YORK and ... (http://www.healthplanone.com ), an innovative online marketplace for health,insurance, ... Series A round,of investment, led by Pequot Ventures. ... Hill, a longtime EVP with Oxford,Health Plans and ...
... ROCKVILLE, Md., April 21 Theranostics Health ... from the National Institutes of,Health (NIH) to ... with protein analysis for cancer diagnostics,and companion ... Theranostics,Health will pay NIH the customary license ...
... in French . , Montreal, April ... tumour cells communicate has just been discovered by the ... of the McGill University Health Centre (MUHC) in collaboration ... cancer cells are able to communicate with their more ...
... tomorrow, medical device company announces significant increase in ... ... Colo., April 21 Baxa Corporation is,committed to manufacturing ... sustainable resources. As a healthcare,products provider, Baxa strives to ...
Other Medicine News:Health News:Review Urges Aggressive MRSA Screening for Health Workers 2Health News:Desert Radiologists Sets Safe Practice Standards 2Health News:Health Plan One Closes $6.5 Million Series A Financing 2Health News:Health Plan One Closes $6.5 Million Series A Financing 3Health News:NIH Grants Exclusive License to Theranostics Health 2Health News:Cancer cells spread by releasing 'bubbles', according to an MUHC study 2Health News:Baxa Environmental Program Nets Significant Results 2Health News:Baxa Environmental Program Nets Significant Results 3
(Date:3/15/2010)... 15 At this year,s ... Cardiology (ACC), March 14-16 in ... PHG, AEX: PHI) will showcase its commitment ... a range of technology advancements.  These care ... information management systems, new temperature modulation therapies, ...
(Date:3/15/2010)... ... , , ... ... ... ALAMOS, N.M. , March 15 Two teams of researchers—including Los Alamos National Laboratory theoretical biologists Bette Korber , Will ...
(Date:3/15/2010)... 15 Abbott (NYSE: ABT ... 101 patients enrolled in the second phase of the ... (BVS), under clinical investigation in Europe , demonstrated ... repeat procedures (ischemia-driven target lesion revascularization) and a very ... of 2.0 percent) at 30 days. These results build ...
Breaking Medicine Technology:Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 2Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 3Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 4Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 5Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 6Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 7Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 8Philips Simplifies Cardiology Care With Technologies That Span the Entire Spectrum of Patient Care 9HIV Vaccine Strategy Expands Immune Responses 2HIV Vaccine Strategy Expands Immune Responses 3HIV Vaccine Strategy Expands Immune Responses 4Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology 2Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology 3Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology 4Abbott Announces Positive Data From ABSORB Trial on Its Bioresorbable Vascular Scaffold Technology 5New Director of Bioanalytical Services Joins Toxikon 15326 1Octapharma Receives Orphan Drug Exclusivity Approval for wilate 28R 29 A Replacement Therapy Developed Specifically for von Willebrand Disease 7355 1Octapharma Receives Orphan Drug Exclusivity Approval for wilate 28R 29 A Replacement Therapy Developed Specifically for von Willebrand Disease 7355 2Octapharma Receives Orphan Drug Exclusivity Approval for wilate 28R 29 A Replacement Therapy Developed Specifically for von Willebrand Disease 7355 3Octapharma Receives Orphan Drug Exclusivity Approval for wilate 28R 29 A Replacement Therapy Developed Specifically for von Willebrand Disease 7355 4Octapharma Receives Orphan Drug Exclusivity Approval for wilate 28R 29 A Replacement Therapy Developed Specifically for von Willebrand Disease 7355 5Octapharma Receives Orphan Drug Exclusivity Approval for wilate 28R 29 A Replacement Therapy Developed Specifically for von Willebrand Disease 7355 6Jedi Mind Receives Vast Media Coverage at CES in Las Vegas 11410 1Jedi Mind Receives Vast Media Coverage at CES in Las Vegas 11410 2Jedi Mind Receives Vast Media Coverage at CES in Las Vegas 11410 3
... N.C.--(BUSINESS WIRE)--May 17, 2007 - Salix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) ... to the Company's products,will be presented at Digestive ... 2007. Digestive Disease Week is considered the,largest and ... GI,professional. Every year it attracts more than 16,000 ...
... at Society for Investigative Dermatology, FREEPORT, N.Y., ... announced new comparative clinical data that indicates,that ... recognize, transport and,utilize L-ergothioneine (EGT) as a ... acts as a more powerful and,efficient antioxidant ...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5AGI Dermatics Presents Comparative Data That Indicates OCTN-1 Skin,Cells Have the Ability to Recognize, Transport and Utilize,L-ergothioneine (EGT) As A Protector Against Oxidative Damage 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: